|
|||||
|
Latest Insider Trading | Top Insider Trading Recent Week | Top 10% Owner Trading Recent Week | Filter |
Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Form 4 |
---|---|---|---|---|---|---|---|---|---|
HUM | BEVERIDGE, ROY A | Chief Medical Officer | Feb 19 | Option Exercise | 167.81 | 7,680 | 1,288,742 | 19,169 | Feb 21 10:24 AM |
HUM | BEVERIDGE, ROY A | Chief Medical Officer | Feb 19 | Sale | 307.16 | 8,278 | 2,542,653 | 10,891 | Feb 21 10:24 AM |
HUM | BEVERIDGE, ROY A | Chief Medical Officer | Dec 15 | Option Exercise | 0.00 | 2,277 | 0 | 12,037 | Dec 18 11:48 AM |
HUM | BEVERIDGE, ROY A | Chief Medical Officer | Nov 08 | Sale | 341.06 | 4,622 | 1,576,395 | 10,621 | Nov 13 09:47 AM |
HUM | BEVERIDGE, ROY A | Chief Medical Officer | Aug 06 | Option Exercise | 158.04 | 16,204 | 2,560,948 | 29,549 | Aug 08 11:01 AM |
HUM | BEVERIDGE, ROY A | Chief Medical Officer | Aug 06 | Sale | 324.25 | 14,306 | 4,638,758 | 15,243 | Aug 08 11:01 AM |
HUM | BEVERIDGE, ROY A | Chief Medical Officer | Feb 24 | Option Exercise | 0.00 | 3,174 | 0 | 15,135 | Feb 27 06:31 PM |
HUM | BEVERIDGE, ROY A | Sr. VP & Chief Medical Officer | Dec 15 | Option Exercise | 0.00 | 1,935 | 0 | 12,938 | Dec 19 12:13 PM |
HUM | BEVERIDGE, ROY A | Sr. VP & Chief Medical Officer | May 12 | Option Exercise | 92.25 | 29,376 | 2,709,961 | 38,037 | May 15 04:45 PM |
HUM | BEVERIDGE, ROY A | Sr. VP & Chief Medical Officer | Feb 18 | Option Exercise | 0.00 | 10,651 | 0 | 18,439 | Feb 22 06:47 PM |
HUM | BEVERIDGE, ROY A | Sr. VP & Chief Medical Officer | Feb 22 | Sale | 205.73 | 4,832 | 994,090 | 8,931 | Feb 22 06:47 PM |
HUM | BEVERIDGE, ROY A | Sr. VP & Chief Medical Officer | Dec 20 | Option Exercise | 81.80 | 8,500 | 695,258 | 13,760 | Dec 22 09:57 AM |
HUM | BEVERIDGE, ROY A | Sr. VP & Chief Medical Officer | Dec 15 | Option Exercise | 0.00 | 1,092 | 0 | 5,811 | Dec 19 03:31 PM |
HUM | BEVERIDGE, ROY A | Sr. VP & Chief Medical Officer | Jun 17 | Option Exercise | 0.00 | 7,947 | 0 | 7,947 | Jun 20 05:10 PM |
Join thousands of traders who make more informed decisions with our premium features. Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite